Suppr超能文献

儿童肝移植术后胆道并发症的内镜逆行胰胆管造影处理-一项回顾性研究。

Endoscopic retrograde cholangio-pancreatography in the management of biliary complications after paediatric liver transplantation - a retrospective study.

机构信息

Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore, Singapore.

Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

出版信息

Transpl Int. 2018 Mar;31(3):313-317. doi: 10.1111/tri.13091. Epub 2017 Nov 23.

Abstract

The published paediatric experience with endoscopic retrograde cholangio-pancreatography (ERCP) in the diagnosis and management of biliary complications following liver transplantation (LT) is limited. We describe our experience with ERCP in the management of children following LT who presented with biliary complications, over a 20-year period (1995-2014). The retrospectively reviewed data are summarized descriptively. Of 94 children (47 boys) who received 102 liver transplants at our centre, seven children (five boys, two girls) underwent ERCP after liver transplantation. In total, 25 ERCP procedures were carried out in these patients. The median age at liver transplantation was 10.7 (3.9-16.2) years. The median interval between LT and the first ERCP was 28 days (12 days-6.8 years). All patients were on standard calcineurin-inhibitor-based immunosuppression regimens. Six of the seven patients underwent ERCP on more than one occasion [median number of ERCP sessions per patient- 4, (1-6)]. Seventeen procedures were carried out under conscious sedation, remaining eight under general anaesthesia. Sedation was achieved employing a standard regimen (Midazolam 5 mg with Pethidine 50 mg) and occasionally Fentanyl. ERCP is an effective and safe intervention from both diagnostic and therapeutic point of view, in the management of post-LT biliary complications in children.

摘要

经内镜逆行胰胆管造影(ERCP)在诊断和治疗肝移植(LT)后胆道并发症方面的儿科应用经验有限。我们描述了在过去 20 年(1995-2014 年)中,我们在 LT 后出现胆道并发症的儿童中进行 ERCP 管理的经验。回顾性分析的数据以描述性方式进行总结。在我们中心接受 102 例肝移植的 94 名儿童(47 名男孩)中,有 7 名儿童(5 名男孩,2 名女孩)在肝移植后接受了 ERCP。在这些患者中总共进行了 25 次 ERCP 检查。肝移植时的中位年龄为 10.7 岁(3.9-16.2 岁)。LT 与第一次 ERCP 之间的中位时间间隔为 28 天(12 天-6.8 年)。所有患者均接受标准的钙调神经磷酸酶抑制剂为基础的免疫抑制方案。7 名患者中有 6 名接受了不止一次 ERCP [每位患者的 ERCP 治疗次数中位数-4 次(1-6 次)]。17 次检查在清醒镇静下进行,其余 8 次在全身麻醉下进行。镇静采用标准方案(咪达唑仑 5mg 联合哌替啶 50mg),偶尔使用芬太尼。从诊断和治疗的角度来看,ERCP 是一种有效且安全的干预措施,可用于治疗 LT 后儿童的胆道并发症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验